Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
安进(US:AMGN) Zacks Investment Research·2024-01-30 02:11Amgen公司业绩 - Amgen (AMGN)属于Zacks Medical - Biomedical and Genetics行业，过去两个季度一直表现出色[1] - 上个季度，Amgen的每股收益为4.96美元，超过了Zacks Consensus Estimate的4.65美元，意味着6.67%的惊喜[3] - Amgen目前的Earnings ESP为+1.01%，分析师对其近期盈利潜力持乐观态度[7]